🔎 Trials Near Me

Home › Schizophrenia › Florida › Hollywood

Pag-aaral pangklinika para sa Schizophrenia sa Hollywood, FL

14 pag-aaral para sa Schizophrenia ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Hollywood (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

Nagre-recruitPhase 3
  • CenExel, Hollywood
Edad 13 hanggang 17 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07288567

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

Nagre-recruitPhase 3
  • Research Centers of America - Hollywood - CenExel - PPDS, Hollywood
Edad 5 hanggang 17 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07424404

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

Nagre-recruitPhase 3
  • Research Centers of America ( Hollywood ), Hollywood
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07686263

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

Nagre-recruitPhase 2
  • Clinical Site, Hollywood
  • Clinical Site, Hollywood
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT07459647

A Study of Brenipatide in Adult Participants With Schizophrenia

Nagre-recruitPhase 2
  • NextPhase Research Florida - Hollywood, Hollywood
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT07410507

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

Nagre-recruitPhase 3
  • Neurocrine Clinical Site, Hollywood
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07227818

NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Nagre-recruitPhase 3
  • Neurocrine Clinical Site, Hollywood
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07105098

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Nagre-recruitPhase 3
  • Neurocrine Clinical Site, Hollywood
  • Neurocrine Clinical Site, Aventura · 4 mi ang layo
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07114874

A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

Nagre-recruitPhase 1
  • Behavioral Clinical Research, Inc., Hollywood
  • CenExel Hollywood FL, Hollywood
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07734493

52-week Open Label Safety-Tolerability Study

Nagre-recruitPhase 3
  • CenExel, Hollywood
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07369154

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

Nagre-recruitPhase 1
  • Research Centers of America ( Hollywood ), Hollywood
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07061288

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Nagre-recruitPhase 3
  • Neurocrine Clinical Site, Hollywood
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Mar 6, 2026 · NCT06963034

Study of ALTO-101 in Patients With Schizophrenia

Nagre-recruitPhase 2
  • Site 5060, Hollywood
Edad 21 hanggang 55 · Lahat ng kasarian · Na-update Dis 26, 2025 · NCT06502964

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
  • Reviva site, Hollywood
  • Reviva site, Hollywood
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Dis 19, 2024 · NCT05184335

Pag-aaral para sa Schizophrenia sa ibang lungsod

Iba pang pag-aaral sa Hollywood

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.